More articles from Volume 31, Issue 3, 2015
Genetip-fenotip korelacija kod spinalne mišićne atrofi je (SMA)
Uporan kašalj kao prvi simptom karcinoma bubrega
Multidisciplinary surgical approach in patient with schwannomatosis in the Clinical Hospital Center Zemun
Case report of lysterious menigitis -Underestimated identity
Gastroschisis -a case report
Article views
Genetip-fenotip korelacija kod spinalne mišićne atrofi je (SMA)
,
Marija Knežević
,
Jelena Mladenović
,
Gordana Kovačević
,
Slavica Ostojić
,
Jelena Milin-Lazovića
Vedrana Milić-Rašić
Published: 01.12.2014.
Biochemistry
Volume 31, Issue 3 (2015)
pp. 1337-1344;
Abstract
Keywords
References
1.
Nurputra D, Poh S, Lai. Spinal Muscular Atrophy: From Gene Discovery to Clinical Trials. Annals of Human Genetics. 2013;435–63.
2.
Ogino S, Wilson R. Genetic testing and risk assessment for spinal muscular atrophy (SMA). Hum Genet. 2002;477–500.
3.
Prior T, Snyder P, Britton D, Rink. Newborn and carrier screening for spinal muscular atrophy. American Journal of Medical Genetics Part A. 2010;1608–16.
4.
Ashrafzadeh F, Sadr-Nabavi A, Asadian N. International Journal of Pediatrics. 2014;211–5.
5.
Melki J, Abdelhak S, Sheth P. Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q. Nature. 1990;(6268):767–8.
6.
Mesfin, Sponseller A, Leet. Spinal muscular atrophy: manifestations and management. 2012;393–401.
7.
Pearn J. Classification of spinal muscular atrophies. Lancet. 1980;(8174):919–22.
8.
Munsat T, Davies K. Neuromuscul Disord. 26AD;423–8.
9.
Zerres K, Rudnik-Schöneborn S, Forrest. A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients. J Neurol Sci. 1997;67–72.
10.
Nigro M. Spinal muscular atrophy. 2005;
11.
Russman B. Spinal Muscular Atrophy: Clinical Classification and Disease Heterogeneity. J Child Neurol. 2007;946–51.
12.
D’amico A, Mercuri E, Tiziano F. Spinal muscular atrophy. Orphanet J Rare Dis. 2011;71.
13.
Kolb S, Kissel J. Spinal Muscular Atrophy:A Timely Review Arch Neurol. 2011;979–84.
14.
Brzustowicz L, Lehner T, Castilla L. Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature. 1990;540–1.
15.
Gilliam T, Brzustowicz L, Castilla L. Genetic homogeneity between acute and chronic forms of spinal muscular atrophy. Nature. 1990;823–5.
16.
Lefebvre S, Burglen L, Reboullet S. LIdentification and characterization of a spinal muscular atrophydetermining gene. Cell. 1995;155–65.
17.
Wirth B. An Update of the Mutation Spectrum of the Survival Motor Neuron Gene (SMN1) in Autosomal Recessive Spinal Muscular Atrophy (SMA). Hum Mutat. 2000;228–37.
18.
Ogino S, Wilson R, Gold B. New insights on the evolution of the SMN1 and SMN2 region: simulation and metaanalysis for allele and haplotype frequency calculations. Eur J Hum Genet. 2004;1015–23.
19.
Mailman M, Heinz J, Papp A. Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet Med. 2002;20–6.
20.
Feldkotter M, Schwarzer V, Wirth R. Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet. 2002;358–68.
21.
Anhuf D, Eggermann T, Rudnik-Schoneborn S. Determination of SMN1 and SMN2 copy number using TaqMan technology. Hum Mutat. 2003;74.
22.
Su Y, Hung C, Li H. Quantitative Analysis of SMN1 and SMN2 Genes Based on DHPLC: A Highly Efficient and Reliable Carrier-Screening Test. Hum Mutat. 2005;460–7.
23.
Campbell L, Potter A, Ignatius. Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am J Hum Genet. 1997;40–50.
24.
Emery A. Population frequencies of inherited neuromuscular diseases -a word survey. Neuromuscul Disord. 1991;19–29.
25.
Wirth B, Herz M, Wetter A. Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. Am J Hum Genet. 1999;1340–56.
26.
Burghes A. When Is a Deletion Not a Deletion? When It Is Converted. Am J Hum Genet. 1997;9–15.
27.
Qu Y, Song F, Yang Y. Compound heterozygous mutation in two unrelated cases of Chinese spinal muscular atrophy patients. Chin Med J (Engl). 2011;(3):385–9.
28.
Clermont O, Burlet P, Benit P. Molecular analysis of SMA patients without homozygous SMN1 deletions using a new strategy for identification of SMN1 subtle mutations. Hum Mutat. 2004;417–27.
29.
Susan M Kirwin, Kathy MB, Vinette I, Gonzalez. A homozygous double mutation in SMN1: a complicated genetic diagnosis of SMA. Mol Genet Genomic Med. 2013;(2):113–7.
30.
Rudnik-Schöneborn S, Eggermann T, Kress W. Clinical utility gene card for: Proximal spinal muscular atrophy (SMA) -update 2015. European Journal of Human Genetics. 2012;(6).
31.
Cobben J, Van Der Steege G, Grootscholten P. Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy. Am J Hum Genet. 1995;805–8.
32.
Rodrigues N, Owen N, Talbot K. Gene deletion in spinal muscular atrophy. J Med Genet. 1996;(2):93–6.
33.
Yamashita M, Nishio H, Harada Y, Matsuo M, Yamamoto T. Significant increase in the number of the SMN2 gene copies in an adult-onset Type III spinal muscular atrophy patient with homozygous deletion of the NAIP gene. Eur Neurol. 2004;101–6.
34.
Harada Y, Sutomo R, Sadewa A, Akutsu T. Correlation between SMN2 copy number and clinical phenotype of spinal muscular atrophy: three SMN2 copies fail to rescue some patients from the disease severity. J Neurol. 2002;1211–9.
35.
Prior T, Krainer A, Hua Y. A Positive Modifier of Spinal Muscular Atrophy in the SMN2 Gene. Am J Hum Genet. 2009;(3):408–13.
36.
Brkušanin M, Kosać A, Jovanović V, Pešović J, Brajušković G, Dimitrijević N, et al. Joint effect of the SMN2 and SERF1A genes on childhood-onset types of spinal muscular atrophy in Serbian patients. Journal of Human Genetics. 2015;60(11):723–8.
37.
Au tor za korespondenciju: Vedrana Milić Rašić, profesor na Medicinskom fakultetu u Beogradu; Klinika za neurologiju i psihijatriju za decu i omladinu, Dr Subotića 6A, 11000 Beograd.
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
